Daniel P. Petrylak, Mauricio Burotto, Felipe Reyes-Cosmelli, Hernan Javier Cutuli, Robert A. Huddart, Tamta Makharadze, José Pablo Maroto Rey, Danish Mazhar, Imanol Martinez Salas, Peter Sankey, Ho Kyung Seo, Cong Xu, Leslie R. DeMars, Michael Method, Yohann Loriot. "Interim analysis results from Duravelo-2: Zelenectide pevedotin (zele; BT8009) in patients (pts) with previously treated locally advanced/metastatic urothelial carcinoma (la/mUC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4566